We found that the patients with BC were characterised by the lower (p < 0.01) methylation level of the SOD2 promoter region (Fig. 5A) and higher NOS2 promoter methylation (p < 0.001) compared to the controls (Fig. 5B). The gene discussed is SOD2; the disease is breast cancer.